Home

BridgeBio Pharma, Inc.

CIK 1743881 · last filed 2025-10-16

BridgeBio Pharma, Inc. is a corporate insider who has filed 10 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for BBOT, was dated Oct 16, 2025. Across all open-market trades the lifetime net is +$117.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $113.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$113.07M

Companies

2

Total Filings

10

Lifetime Open-Market Net

$117.87M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BBOT 10%+ Owner 14,589,846 $7.75 $113.07M $0 1 2025-10-16
Eidos Therapeutics, Inc. (EIDX) Delisted 10%+ Owner 24,576,501 — — $117.87M 9 2021-01-26

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-10-16 BBOT Other (J) +1,569,440 $0 EDGAR
2021-01-26 Eidos Therapeutics, Inc. (EIDX) Delisted Buy (P) +14,428,836 $0 EDGAR
2019-07-08 Eidos Therapeutics, Inc. (EIDX) Delisted Buy (P) +882,353 $26.38M EDGAR
2019-05-29 Eidos Therapeutics, Inc. (EIDX) Delisted Buy (P) +1,103,848 $28.62M EDGAR
2018-12-13 Eidos Therapeutics, Inc. (EIDX) Delisted Buy (P) +80,144 $1.10M EDGAR
2018-12-13 Eidos Therapeutics, Inc. (EIDX) Delisted Buy (P) +40,653 $542.1K EDGAR
2018-12-12 Eidos Therapeutics, Inc. (EIDX) Delisted Sell (S) +40,653 $542.1K EDGAR
2018-12-10 Eidos Therapeutics, Inc. (EIDX) Delisted Sell (S) +80,144 $1.10M EDGAR
2018-12-06 Eidos Therapeutics, Inc. (EIDX) Delisted Buy (P) +2,853,848 $42.59M EDGAR
2018-06-26 Eidos Therapeutics, Inc. (EIDX) Delisted Mixed +19,614,655 $13.40M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.